Treatment of Post-transplant Lymphocele in Children

Romy Gander1, Marino Asensio1, Gloria Fatou Royo1

  • 1Pediatric Urology and Renal Transplant Unit, Department of Pediatric Surgery, Hospital Vall d'Hebron, Barcelona, Spain.

Urology
|January 31, 2017
PubMed

Insights

Post-transplant lymphoceles in pediatric kidney recipients are common. Percutaneous catheter drainage and transcatheter sclerotherapy offer safe and effective management, though they may prolong hospitalization.

Area of Science:

  • Pediatric Nephrology
  • Transplant Surgery
  • Urology

Background:

  • Post-transplant lymphoceles are known complications following pediatric kidney transplantation (KT).
  • Current literature lacks a consensus on the optimal management strategy for pediatric post-transplant lymphoceles.
  • This study reviews a single center's experience in managing these complications.

Purpose of the Study:

  • To evaluate the management and outcomes of post-transplant lymphoceles in pediatric kidney transplant recipients.
  • To assess the safety and efficacy of different treatment modalities.
  • To contribute to the limited literature on this topic.

Main Methods:

  • Retrospective review of a single institutional database.
  • Inclusion criteria: pediatric KT recipients who developed lymphoceles between January 2000 and December 2015.
  • Diagnostic procedures included ultrasound; treatments involved observation, percutaneous catheter drainage, and transcatheter sclerotherapy (TS).

Main Results:

  • Lymphoceles occurred in 9 out of 176 (5.1%) pediatric KT recipients.
  • Asymptomatic lymphoceles (n=3) resolved spontaneously. Symptomatic cases (n=6) were treated with drainage or TS.
  • Transcatheter sclerotherapy (TS) with povidone-iodine was initially used, with some cases requiring alternative agents (polidocanol) or open drainage.
  • No graft loss or recurrence was observed during a mean follow-up of 30.3 months.

Conclusions:

  • There is no established gold-standard treatment for pediatric post-transplant lymphoceles.
  • Percutaneous catheter drainage, with or without transcatheter sclerotherapy (TS), is a safe and effective approach.
  • While effective, these interventions may increase hospitalization duration and morbidity.
Abstract